SSTR5-AS1
gene geneOn this page
Summary
SSTR5-AS1 (SSTR5 antisense RNA 1, HGNC:26502) is a long non-coding RNA gene on chromosome 16p13.3.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26502 |
| Approved symbol | SSTR5-AS1 |
| Name | SSTR5 antisense RNA 1 |
| Location | 16p13.3 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000261713 |
| Ensembl biotype | lncRNA |
| Entrez | 146336 |
| RNAcentral | URS000075EBD1 — lncRNA, 2948 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 7 lncRNA
ENST00000565992, ENST00000566499, ENST00000569734, ENST00000569832, ENST00000624643, ENST00000711618, ENST00000711619
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000565992 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002577061 | 1066919 | 1067043 |
| ENSE00002590856 | 1064087 | 1066526 |
| ENSE00002622402 | 1073566 | 1073645 |
| ENSE00004016203 | 1073087 | 1073219 |
Expression profiles
Bgee: expression breadth ubiquitous, 131 present calls, max score 96.54.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.4414 / max 94.5545, expressed in 105 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 155806 | 0.4202 | 98 |
| 155805 | 0.0120 | 6 |
| 155807 | 0.0091 | 5 |
Top tissues by expression
209 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 96.54 | gold quality |
| oocyte | CL:0000023 | 93.86 | gold quality |
| right atrium auricular region | UBERON:0006631 | 79.31 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.80 | gold quality |
| apex of heart | UBERON:0002098 | 78.75 | gold quality |
| cardiac atrium | UBERON:0002081 | 78.69 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 78.44 | silver quality |
| right adrenal gland cortex | UBERON:0035827 | 78.15 | gold quality |
| left adrenal gland | UBERON:0001234 | 77.53 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 77.49 | gold quality |
| adrenal cortex | UBERON:0001235 | 76.61 | gold quality |
| adrenal gland | UBERON:0002369 | 76.50 | gold quality |
| right adrenal gland | UBERON:0001233 | 75.81 | gold quality |
| islet of Langerhans | UBERON:0000006 | 73.09 | gold quality |
| heart left ventricle | UBERON:0002084 | 71.52 | gold quality |
| heart | UBERON:0000948 | 71.15 | gold quality |
| cardiac ventricle | UBERON:0002082 | 71.12 | gold quality |
| metanephros cortex | UBERON:0010533 | 68.75 | gold quality |
| tibia | UBERON:0000979 | 67.32 | gold quality |
| cartilage tissue | UBERON:0002418 | 65.86 | silver quality |
| duodenum | UBERON:0002114 | 65.07 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 64.77 | gold quality |
| ascending aorta | UBERON:0001496 | 64.53 | gold quality |
| thoracic aorta | UBERON:0001515 | 64.35 | gold quality |
| superior surface of tongue | UBERON:0007371 | 64.25 | gold quality |
| pancreas | UBERON:0001264 | 63.53 | gold quality |
| minor salivary gland | UBERON:0001830 | 62.35 | gold quality |
| sural nerve | UBERON:0015488 | 62.33 | silver quality |
| pituitary gland | UBERON:0000007 | 61.63 | gold quality |
| adenohypophysis | UBERON:0002196 | 61.45 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.54 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 6)
- SSTR5-AS1 may play antitumor role in LSCC and may be regulated by the hypermethylation of the same CpG sites with SSTR5. SSTR5-AS1 inhibits laryngeal carcinoma cells proliferation, migration, and invasion. (PMID:31196171)
- The present study suggests that SSTR5AS1 functions as a competing endogenous RNA to regulate CA2 by sponging miR15b5p for the development and prognosis of hepatitis B virus related hepatocellular carcinoma. (PMID:31638225)
- Long non-coding RNA SSTR5-AS1 facilitates gemcitabine resistance via stabilizing NONO in gallbladder carcinoma. (PMID:31810606)
- Diagnostic and prognostic significance of long noncoding RNA SSTR5-AS1 in patients with gastric cancer. (PMID:32495873)
- lncRNA SSTR5-AS1 Predicts Poor Prognosis and Contributes to the Progression of Esophageal Cancer. (PMID:36726845)
- LncRNA SSTR5-AS1 as a Prognostic Marker Promotes Cell Proliferation and Epithelial-to-Mesenchymal Transition in Prostate Cancer. (PMID:36734853)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.